D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
Microsoft
MSFT
|
+$524M |
| 4 |
T-Mobile US
TMUS
|
+$411M |
| 5 |
Uber
UBER
|
+$406M |
Top Sells
| 1 |
Visa
V
|
+$567M |
| 2 |
Charles Schwab
SCHW
|
+$531M |
| 3 |
Apple
AAPL
|
+$484M |
| 4 |
Johnson & Johnson
JNJ
|
+$455M |
| 5 |
Accenture
ACN
|
+$401M |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Industrial Select Sector SPDR Fund
XLI
$23.2B
| $13.2M | 0.01% |
+122,938
| New | +$13.2M |
|
652
Immunocore
IMCR
$1.83B
| $13.2M | 0.01% |
219,959
-94,480
| -30% | -$5.67M |
|
653
Intapp
INTA
$3.65B
| $13.2M | 0.01% |
314,050
+169,884
| +118% | +$7.12M |
|
654
Royalty Pharma
RPRX
$15.6B
| $13.1M | 0.01% |
426,602
+96,782
| +29% | +$2.98M |
|
655
LivePerson
LPSN
$89.1M
| $13.1M | 0.01% |
2,897,581
+1,105,323
| +62% | +$5M |
|
656
Cencora
COR
$57.4B
| $13.1M | 0.01% |
68,058
-34,148
| -33% | -$6.57M |
|
657
DTE Energy
DTE
$28.2B
| $13.1M | 0.01% |
118,802
-90,564
| -43% | -$9.96M |
|
658
Sprinklr
CXM
$1.88B
| $13M | 0.01% |
940,398
+603,391
| +179% | +$8.34M |
|
659
NOV
NOV
$4.85B
| $13M | 0.01% |
809,159
+626,888
| +344% | +$10.1M |
|
660
PG&E
PCG
$33.5B
| $12.9M | 0.01% |
748,439
+461,984
| +161% | +$7.98M |
|
661
Omnicell
OMCL
$1.46B
| $12.9M | 0.01% |
175,450
-226,446
| -56% | -$16.7M |
|
662
Oneok
OKE
$46.2B
| $12.9M | 0.01% |
209,211
-195,180
| -48% | -$12M |
|
|
LGF.A
663
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $12.9M | 0.01% |
1,460,284
+313,869
| +27% | +$2.77M |
|
|
CHX
664
DELISTED
ChampionX
CHX
| $12.9M | 0.01% |
415,084
-346,612
| -46% | -$10.8M |
|
665
Tenaris
TS
$18.5B
| $12.8M | 0.01% |
428,703
+313,435
| +272% | +$9.39M |
|
666
Viavi Solutions
VIAV
$2.66B
| $12.8M | 0.01% |
1,131,407
-197,034
| -15% | -$2.23M |
|
667
AES
AES
$9.06B
| $12.8M | 0.01% |
616,690
+253,759
| +70% | +$5.26M |
|
668
FirstCash
FCFS
$6.46B
| $12.8M | 0.01% |
136,711
+38,256
| +39% | +$3.57M |
|
|
DNAB
669
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
| $12.8M | 0.01% |
1,231,848
| – | – |
|
|
BKDT
670
DELISTED
Brookdale Senior Living Inc. 7.00% Tangible Equity Units
BKDT
| $12.8M | 0.01% |
205,000
-25,000
| -11% | -$1.56M |
|
671
Pool Corp
POOL
$11.9B
| $12.7M | 0.01% |
33,833
-250
| -0.7% | -$93.7K |
|
672
Arlo Technologies
ARLO
$1.77B
| $12.7M | 0.01% |
1,159,853
-465,069
| -29% | -$5.07M |
|
673
MYR Group
MYRG
$2.77B
| $12.6M | 0.01% |
91,263
+32,235
| +55% | +$4.46M |
|
|
AVDL
674
Avadel Pharmaceuticals
AVDL
$1.54B
| $12.6M | 0.01% |
765,836
+454,546
| +146% | +$7.49M |
|
675
Axcelis
ACLS
$2.62B
| $12.6M | 0.01% |
68,510
+18,221
| +36% | +$3.34M |
|